by dorlybuchi@bonaireswiss.ch | May 23, 2019 | cancer, research, science
Different cells, like leukocytes, fibroblasts, and vascular endothelial cells together form a tumor microenvironment. The leukocytes interact with tumor cells to influence the development of tumors. In general, monocytes/macrophages can be polarized to M1 or M2...
by dorlybuchi@bonaireswiss.ch | May 14, 2019 | cancer, research, science
Metastatic melanoma is the most aggressive form of skin cancer, and the most rapidly expanding cancer in terms of worldwide incidence with a 5 years survival rate of less than 10% after metastasis establishment. Besides that, chemo and radiotherapeutic approaches in...
by dorlybuchi@bonaireswiss.ch | May 9, 2019 | cancer, research, science
CYTOKINES PROFILE PRODUCED BY MACROPHAGES DURING Leishmania amazonensis INTERACTION AFTER Thuya 30 cH AND M1 COMPLEX TREATMENT Background: Leishmaniasis is a major vector-borne metazoonosis disease, caused by obligate intramacrophage protozoa of the genus Leishmania....
by dorlybuchi@bonaireswiss.ch | Mar 27, 2019 | cancer, research, science
Cytokine is a general term for a large group of molecules involved in signaling between cells during immune responses and are produced by different cell types. Its production triggers a cascade of reactions, influences the synthesis of other cytokines and can exert...
by dorlybuchi@bonaireswiss.ch | Mar 22, 2019 | cancer, flu, research, science
A BIOLOGIC RESPONSE MODIFIER AGAINST MELANOMA. Metastatic melanoma is the most aggressive form of skin cancer, and the most rapidly expanding cancer in terms of worldwide incidence, with a 5 years survival rate of less than 10% after metastasis establishment. Chemo...
by dorlybuchi@bonaireswiss.ch | Jan 15, 2019 | cancer, flu, research, science
Inflammatory mammary carcinoma (IMC) is locally aggressive, fast growing, a highly malignant tumor that affects humans and dogs. Affected dogs usually are presented with generalized edema, pain, erythema, and skin ulceration in mammary glands. Surgery is not...
